These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27576073)

  • 41. Increasing postpartum rate of vaccination with tetanus, diphtheria, and acellular pertussis vaccine by incorporating pertussis cocooning information into prenatal education for group B streptococcus prevention.
    Cheng PJ; Huang SY; Su SY; Peng HH; Chang CL
    Vaccine; 2015 Dec; 33(51):7225-7231. PubMed ID: 26549365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of a training intervention on immunization to increase knowledge of primary healthcare workers and vaccination coverage rates.
    Uskun E; Uskun SB; Uysalgenc M; Yagiz M
    Public Health; 2008 Sep; 122(9):949-58. PubMed ID: 18313703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.
    Talbot EA; Brown KH; Kirkland KB; Baughman AL; Halperin SA; Broder KR
    Vaccine; 2010 Nov; 28(50):8001-7. PubMed ID: 20875487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of pertussis immunization in health-care personnel.
    Walther K; Burckhardt MA; Erb T; Heininger U
    Vaccine; 2015 Apr; 33(17):2009-14. PubMed ID: 25776922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of vaccine mandate on Tdap vaccination coverage among Illinois students 2014-15.
    Karikari Y; Akinyede O; Davis V; Soyemi K
    Pan Afr Med J; 2017; 27():103. PubMed ID: 28819524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.
    Halperin BA; MacDougall D; MacKinnon-Cameron D; Li L; McNeil SA; Langley JM; Halperin SA
    Vaccine; 2015 Nov; 33(48):6840-8. PubMed ID: 26392011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
    Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
    Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance of Increased Childhood Influenza Vaccination Rates 1 Year After an Intervention in Primary Care Practices.
    Nowalk MP; Zimmerman RK; Lin CJ; Reis EC; Huang HH; Moehling KK; Hannibal KM; Matambanadzo A; Shenouda EM; Allred NJ
    Acad Pediatr; 2016; 16(1):57-63. PubMed ID: 26767508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.
    Pichichero ME; Rennels MB; Edwards KM; Blatter MM; Marshall GS; Bologa M; Wang E; Mills E
    JAMA; 2005 Jun; 293(24):3003-11. PubMed ID: 15933223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tdap vaccine: current indications for adolescent and adult patients in the United States.
    Kirchner JT
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S7-9. PubMed ID: 22086895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of pertussis through adult vaccination.
    Suryadevara M; Domachowske JB
    Hum Vaccin Immunother; 2015; 11(7):1744-7. PubMed ID: 25912733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
    Smith JG; Metzger NL
    J Manag Care Pharm; 2011 Nov; 17(9):701-8. PubMed ID: 22050395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Missed opportunities for adolescent vaccination, 2006-2011.
    Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
    J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early Impact of the US Tdap vaccination program on pertussis trends.
    Skoff TH; Cohn AC; Clark TA; Messonnier NE; Martin SW
    Arch Pediatr Adolesc Med; 2012 Apr; 166(4):344-9. PubMed ID: 22213608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Strassberg ER; Power M; Schulkin J; Stark LM; Mackeen AD; Murtough KL; Paglia MJ
    Vaccine; 2018 Jul; 36(30):4548-4554. PubMed ID: 29907484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Waning Tdap Effectiveness in Adolescents.
    Klein NP; Bartlett J; Fireman B; Baxter R
    Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.